← Eichor
Condition: Recurrent Adenoid Cystic Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Adenoid Cystic Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Phase 1/Phase 2 · 9 location(s) · Remix Therapeutics · NCT06118086Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Phase N/A · 4 location(s) · Vanderbilt University Medical Center · NCT00898638CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
Phase 1/Phase 2 · 1 location(s) · Glenn J. Hanna · NCT05774899A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Re
Phase 2 · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT07522879Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma
Phase 2 · 1 location(s) · HitGen Inc. · NCT06781567Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT01473784A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06891560Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07162480
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.